Swiss All Share Index
15.101,67
PKT
-275,86
PKT
-1,79
%
Werbung
Analysen zu Swiss All Share Index-Werten
Datum | Rating | Analyst | |
---|---|---|---|
23.09.24 | Nestlé Sector Perform | RBC Capital Markets | |
20.09.24 | DocMorris Buy | Jefferies & Company Inc. | |
20.09.24 | Richemont Buy | Jefferies & Company Inc. | |
20.09.24 | Givaudan Hold | Deutsche Bank AG | |
20.09.24 | DocMorris Sell | UBS AG | |
20.09.24 | Nestlé Neutral | UBS AG | |
20.09.24 | Richemont Buy | Goldman Sachs Group Inc. | |
19.09.24 | Zurich Insurance Overweight | Barclays Capital | |
19.09.24 | Zurich Insurance Overweight | Barclays Capital | |
19.09.24 | Swiss Re Equal Weight | Barclays Capital | |
19.09.24 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
19.09.24 | ams-OSRAM Equal Weight | Barclays Capital | |
18.09.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
18.09.24 | Givaudan Underperform | Jefferies & Company Inc. | |
18.09.24 | Givaudan Buy | Goldman Sachs Group Inc. | |
18.09.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
18.09.24 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
18.09.24 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
17.09.24 | Givaudan Neutral | UBS AG | |
17.09.24 | Givaudan Neutral | UBS AG | |
17.09.24 | Givaudan Underperform | Jefferies & Company Inc. | |
17.09.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
17.09.24 | Richemont Overweight | Barclays Capital | |
16.09.24 | Roche Sell | Goldman Sachs Group Inc. | |
16.09.24 | Roche Neutral | UBS AG | |
13.09.24 | Swiss Re Sector Perform | RBC Capital Markets | |
13.09.24 | Givaudan Neutral | UBS AG | |
13.09.24 | Roche Sell | Deutsche Bank AG | |
12.09.24 | Roche Sell | Goldman Sachs Group Inc. | |
11.09.24 | DocMorris Sell | UBS AG | |
11.09.24 | Novartis Buy | UBS AG | |
11.09.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
10.09.24 | Roche Neutral | UBS AG | |
10.09.24 | Roche Sell | Goldman Sachs Group Inc. | |
10.09.24 | DocMorris Add | Baader Bank | |
10.09.24 | Richemont Outperform | Bernstein Research | |
10.09.24 | Roche Hold | Deutsche Bank AG | |
10.09.24 | Roche Underweight | JP Morgan Chase & Co. | |
09.09.24 | Roche Neutral | UBS AG | |
09.09.24 | Givaudan Neutral | UBS AG |